Biofrontera AG (XTER:B8FK) YoY EBITDA Growth : 190.26% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Biofrontera AG YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Biofrontera AG's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 190.26%.

Biofrontera AG's EBITDA per Share for the three months ended in Dec. 2023 was €0.79.

Biofrontera AG YoY EBITDA Growth Historical Data

The historical data trend for Biofrontera AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofrontera AG YoY EBITDA Growth Chart

Biofrontera AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

106.37

-432.91

1,052.33

-202.20

97.19

Biofrontera AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															-107.02	89.79	108.54	52.00	190.26

Biofrontera AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Biofrontera AG's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.435	-	-15.455)	/	\| -15.455 \|
=	97.19 %

Biofrontera AG's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(0.788	-	-0.873)	/	\| -0.873 \|
=	190.26 %

Biofrontera AG YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Biofrontera AG's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofrontera AG (XTER:B8FK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofrontera AG (XTER:B8FK) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

B8F:Germany B8F:Germany B8F:Germany

Address

Hemmelrather Weg 201, Leverkusen, NW, DEU, 51377

Website

https://www.biofrontera.com

Biofrontera AG is active in the field of healthcare. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.

Biofrontera AG (XTER:B8FK) Headlines

No Headlines